Press Releases

Active Biotech announce results in ARPEGGIO Phase II trial with laquinimod in Primary Progressive MS
December 1, 2017 13:00 (CET)
Regulatory
Active Biotech's election committee appointed
November 17, 2017 08:30 (CET)
Active Biotech AB - Interim report January - September 2017
November 9, 2017 08:30 (CET)
Regulatory
Active Biotech's partner Teva presents new data on laquinimod for the treatment of multiple sclerosis at 7th joint ECTRIMS-ACTRIMS Meeting
October 19, 2017 14:00 (CEST)
Active Biotech AB - Interim report January - June 2017
August 10, 2017 08:30 (CEST)
Regulatory
Helén Tuvesson new CEO of Active Biotech AB from July 1, 2017
June 19, 2017 15:30 (CEST)
Regulatory
Annual General Meeting of Active Biotech AB
June 16, 2017 08:30 (CEST)
Regulatory
Annual Report 2016 Active Biotech AB (publ)
May 18, 2017 14:30 (CEST)
Regulatory
Active Biotech: Notice of Annual General Meeting of Shareholders
May 17, 2017 08:30 (CEST)
Regulatory
Teva and Active Biotech Announce CONCERTO trial of Laquinimod in RRMS Did Not Meet Primary Endpoint
May 5, 2017 20:00 (CEST)
Regulatory